Radotinib (IY-5511)
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Radotinib is a novel and selective Bcl-Abl tyrosine kinase inhibitor | ||
---|---|---|---|
Targets |
|
Catalog Num | A13029 |
---|---|
Formula | C27H21F3N8O |
Molecular Weight | 530.5 |
CAS Number | 926037-48-1 |
SMILES | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=NC=CN=C5 |
Synonyms | IY-5511 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 94 mg/mL (177.19 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.85 mL | 94.25 mL | 188.5 mL |
0.5 mM | 3.77 mL | 18.85 mL | 37.7 mL |
1 mM | 1.89 mL | 9.43 mL | 18.85 mL |
5 mM | 0.38 mL | 1.89 mL | 3.77 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2